Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
108.89 USD
-0.2%
Market Closed
Updated:
Apr 16, 2024
Abbott Laboratories
Total Liabilities & Equity
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Total Liabilities & Equity Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities & Equity
$73.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities & Equity
$52.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities & Equity
$35.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Liabilities & Equity
$9.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities & Equity
$39.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities & Equity
$15.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
See Also
What is Abbott Laboratories's Total Liabilities & Equity?
Total Liabilities & Equity
73.2B
USD
73.2B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Total Liabilities & Equity amounts to 73.2B USD.
What is Abbott Laboratories's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
5%
5%
Over the last year, the Total Liabilities & Equity growth was -2%.
You don't have any saved screeners yet
